Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Yana Dekempeneer actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 12 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
Onderzoeksoutput
-
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 feb 2020, blz. page 79. 1 blz.Onderzoeksoutput: Poster
-
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 apr 2020, In : Cancers. 12, 4, 1017.Onderzoeksoutput: Article
Open AccessBestand9 Citaten (Scopus)61 Downloads (Pure) -
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.
Dekempeneer, Y., Caveliers, V., Ooms, M., Maertens, D., Gysemans, M., Lahoutte, T., Xavier, C., Lecocq, Q., Maes, K., Covens, P., Miller, B. W., Bruchertseifer, F., Morgenstern, A., Cardinaels, T. & D'Huyvetter, M., 8 sep 2020, In : Molecular Pharmaceutics. 17, 9, blz. 3553-3566 14 blz.Onderzoeksoutput: Article
6 Citaten (Scopus) -
Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy
Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Maertens, D., Gysemans, M., Ooms, M., Lahoutte, T., Xavier, C., Bruchertseifer, F., Morgenstern, A. & Cardinaels, T., 23 mrt 2019, Journal of Medical Imaging and Radiation Sciences. 1 redactie Elsevier, Vol. 50. blz. S7-S8 2 blz.Onderzoeksoutput: Conference paper
Open Access -
Does targeted radionuclide therapy using 177Lutetium induce immune activation upon treatment?
Ertveldt, T., Krasniqi, A., Keyaerts, M., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., De Beck, L., Dekempeneer, Y., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 7 jun 2019.Onderzoeksoutput: Poster
Prijzen
-
INCOVO Price Cancer Research
Yana Dekempeneer (Recipient), dec 2016
Prijs: Prize (including medals and awards)
-
Junior Travel Grant TAT 2017
Yana Dekempeneer (Recipient), 30 mrt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant EANM 2017
Yana Dekempeneer (Recipient), 22 okt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant Research Stay Gothenburg
Yana Dekempeneer (Recipient), 1 mei 2016
Prijs: Prize (including medals and awards)
Activiteiten
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor), Yana Dekempeneer (Contributor)2020Activiteit: Other
-
Combining bismuth-213 with Nanobodies: finding the match for Targeted Alpha Radionuclide Therapy
Yana Dekempeneer (Speaker)1 apr 2019 → 5 apr 2019Activiteit: Talk or presentation at a conference
-
Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer (Speaker)11 mei 2019Activiteit: Talk or presentation at a conference
-
11th International Symposium on Targeted-Alpha-Therapy
Yana Dekempeneer (Participant)1 apr 2019 → 5 apr 2019Activiteit: Participation in conference
-
European Molecular Imaging Meeting - EMIM 2018
Carlien Geldof (Organiser), Yana Dekempeneer (Organiser)21 mrt 2018Activiteit: Participation in conference
Knipsels
-
-
Q&A: Treating cancer with precisely targeted drugs
3/02/17
1 item van Media-aandacht
Pers / media: !!Research
-
-
Jonge wetenschapster krijgt beurs: Yana onderzoekt of kamelen kanker kunnen helpen bestrijden (Het Nieuwsblad)
28/11/15
1 item van Media-aandacht
Pers / media: !!Research
-
Doctoraatsstudente krijgt geld voor baanbrekend kankeronderzoek
12/01/17
1 item van Media-aandacht
Pers / media: !!Research
Scriptie
-
Radiolabeling of nanobodies with Bismuth-213 for Targeted Alpha Therapy
Auteur: Caveliers, V., Rens, L. & Dekempeneer, Y., 5 sep 2019Scriptie/masterproef: Master's Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Ballet, S. & Dekempeneer, Y., sep 2020Begeleider: Ballet, S. (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Hernot, S. & Devoogdt, N., sep 2020Scriptie/masterproef: Doctoral Thesis
-
TARGETED ALPHA THERAPY WITH SINGLE-DOMAIN ANTIBODY FRAGMENTS, A NOVEL CANCER TREATMENT
Auteur: Ballet, S. & Dekempeneer, Y., jun 2020Begeleider: Ballet, S. (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Towards a new, safe adjuvant: The effects of farnesyl pyrophosphate in the adaptive immune response
Auteur: De Kempeneer, Y., Annaert, W. & Liu, W., 2015Scriptie/masterproef: Master's Thesis